CVS HEALTH CORPCVS
ASignal's systematic analysis rates CVS as Neutral.
Reflects the latest available analysis · analyzed Sep 8, 2026
The case on CVS
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Positive MACD histogram expansion indicating strengthening momentum
- Free cash flow of $8.08B supports capital return and reinvestment capacity
- Revenue growth of 7.1% and earnings growth of 188.8% year-over-year
- Forward P/E of 11.36x below current P/E, suggesting earnings growth expectations
- Low PEG ratio of 0.23x indicating potential undervaluation relative to growth
- RSI at 60.15, approaching overbought territory
- Current price near upper Bollinger Band at $97.99, suggesting short-term resistance
- Debt-to-equity ratio of 0.96x approaching high leverage threshold
- Current ratio of 0.87x and quick ratio of 0.62x indicating liquidity pressure
- Net profit margin of 1.18% is low for the healthcare sector
Peers
Clustered with CVS by analysis-profile similarity.
See the full verdict on CVS
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes CVS
Most investors never get a second opinion, let alone several. ASignal runs CVS past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.